Search Results - "Rosenthal, S.A"

Initial Report of NRG Oncology/RTOG 0232: A Phase 3 Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate-Risk Prostatic Carcinoma by Prestidge, B.R, Winter, K, Sanda, M.G, Amin, M, Bice, W.S, Michalski, J, Ibbott, G.S, Crook, J.M, Catton, C.N, Gay, H.A, Donavanik, V, Beyer, D.C, Frank, S.J, Papagikos, M.A, Rosenthal, S.A, Barthold, H.J.J, Roach, M, Sandler, H.M

Get full text

The First Report of NRG Oncology/RTOG 0622: A Phase 2 Trial of Samarium 153 Followed by Salvage Irradiation in High-Risk Nonmetastatic Prostate Cancer After Prostatectomy by Valicenti, R.K, Pugh, S.L, Trabulsi, E, Sartor, O, Girvigian, M.R, Rosenthal, S.A, Shaves, M, Schallenkamp, J.M, Hoffman-Censits, J, Sandler, H.M

Get full text

A Multi-institutional Phase 2 Trial Assessing Quality of Life (QOL) After Electromagnetic Transponder Guided Prostate Stereotactic Body Radiation Therapy (SBRT) by Jackson, W.C, Litzenberg, D.W, Schipper, M, Wei, J, Rosenthal, S.A, Chang, G.C, Horwitz, E.M, Li, J, Michalski, J.M, Gay, H.A, Feng, F.Y, Sandler, H.M, Wallace, R.E, Hamstra, D.A

Get full text

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA by Shipley, W.U, Seiferheld, W, Lukka, H, Major, P, Heney, N.M, Grignon, D, Sartor, O, Patel, M, Bahary, J.P, Zietman, A.L, Pisansky, T.M, Zeitzer, K.L, Lawton, C.A.F, Feng, F.Y, Lovett, R.D, Balogh, A, Souhami, L, Rosenthal, S.A, Kerlin, K.J, Sandler, H.M

Get full text

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG Oncology/RTOG 9202 by Lawton, C.A.F, Dignam, J.J, Hanks, G.E, Lepor, H, Grignon, D, Brereton, H.D, Bedi, M, Rosenthal, S.A, Zeitzer, K.L, Venkatesan, V.M, Horwitz, E.M, Pisansky, T.M, Kim, H, Parliament, M.B, Kwok, Y, Roach, M, Lin, X, Sandler, H.M

Get full text

Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer by Bruner, D. Watkins, Deshmukh, S, Michalski, J.M, Purdy, J.A, Bosch, W.R, Bahary, J.P, Patel, M, Parliament, M.B, Lock, M.I, Lau, H, Hamstra, D.A, Fisher, S.A, Souhami, L, Kwok, Y, Seider, M.J, Vigneault, E, Gay, H.A, Rosenthal, S.A, Sandler, H.M, Movsas, B

Get full text

Nadir Prostate-Specific Antigen After Neoadjuvant Androgen Suppression (AS) in Prostate Cancer Patients Receiving Short-term AS and Radiation Therapy: Pooled Analysis of Four NRG Oncology/RTOG Randomized Clinical Trials by Hallemeier, C.L, Zhang, P, Pisansky, T.M, Hanks, G.E, McGowan, D.G, Roach, M, Zeitzer, K.L, Firat, S, Husain, S.M, D'Souza, D.P, Souhami, L, Parliament, M.B, Rosenthal, S.A, Lukka, H, Rotman, M.Z, Horwitz, E.M, Miles, E, Sandler, H.M

Get full text

Radiation Therapy Oncology Group 9910: Phase 3 Trial to Evaluate the Duration of Neoadjuvant (NEO) Total Androgen Suppression (TAS) and Radiation Therapy (RT) in Intermediate-Risk Prostate Cancer (PCa) by Pisansky, T.M, Hunt, D, Gomella, L.G, Amin, M.B, Balogh, A.G, Chinn, D.M, Seider, M, Duclos, M, Rosenthal, S.A, Sandler, H.M

Get full text

Diabetes and Cardiovascular Mortality in Men With Locally Advanced Prostate Cancer: Updated Analysis From RTOG 92-02 by Mak, K.S, Yan, Y, Smith, M.R, Hanks, G.E, Brereton, H.D, Bauman, G, Rosenthal, S.A, Zeitzer, K.L, Sandler, H.M, Efstathiou, J.A

Get full text

Gleason Pattern 5 is Associated With an Increased Risk for Metastasis Following Androgen Deprivation Therapy (ADT) and Radiation: An Analysis of RTOG 9202 and 9902 by Hamstra, D.A, Hunt, D, Grignon, D, Hanks, G.E, Peters, C.A, Rosenthal, S.A, Lock, M.I, Zeitzer, K.L, Souhami, L, Sandler, H

Get full text

Comparison of Volumetric Modulated Arc Therapy (VMAT) vs. Fixed Field Intensity Modulated Radiation Therapy (IMRT) Techniques for the Treatment of Localized Prostate Cancer by Rosenthal, S.A, Wu, C, Mangat, J.K, Tunnicliff, C.J, Chang, G.C, Dutton, S.C, Goldsmith, B.J, Leibenhaut, M.H, Logsdon, M.D, Asche, D.R

Get full text

American College of Radiology Appropriateness Criteria® — Locally Advanced (High-risk) Prostate Cancer by Ciezki, J.P, Hsu, I.-C.J, Abdel-Wahab, M, Arterbery, V.E, Frank, S.J, Mohler, J.L, Moran, B.J, Rosenthal, S.A, Rossi, C.J, Yamada, Y, Merrick, G

“…Abstract The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2…”
Get full text

The Impact of Overall Treatment Time on Survival and Local Control in Anal Cancer Patients: A Pooled Data Analysis of RTOG Trials 8704 and 9811 by Ben-Josef, E, Moughan, J, Ajani, J, Flam, M, Gunderson, L, Pollock, J, Myerson, R, Anne, R, Rosenthal, S.A, Willett, C

Get full text

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer by Shipley, William U, Seiferheld, Wendy, Lukka, Himanshu R, Major, Pierre P, Heney, Niall M, Grignon, David J, Sartor, Oliver, Patel, Maltibehn P, Bahary, Jean-Paul, Zietman, Anthony L, Pisansky, Thomas M, Zeitzer, Kenneth L, Lawton, Colleen A.F, Feng, Felix Y, Lovett, Richard D, Balogh, Alexander G, Souhami, Luis, Rosenthal, Seth A, Kerlin, Kevin J, Dignam, James J, Pugh, Stephanie L, Sandler, Howard M

“…With a median follow-up of 13 years, a randomized comparison of radiotherapy with or without antiandrogen therapy in patients with a rising PSA level after…”
Get full text

Practices and Perceptions of Survivorship Care in Radiation Oncology: Results from a Nationally Distributed Survey by Frick, M., Rosenthal, S.A., Vapiwala, N., Monzon, B., Berman, A.T.

Get full text

Survivorship Care Training and Education Among Radiation Oncologists: Results from a Nationally-Distributed Survey by Frick, M., Rosenthal, S.A., Vapiwala, N., Monzon, B., Berman, A.T.

Get full text

Validation of a Genomic Classifier in the NRG Oncology/RTOG 0521 Phase III Trial of Docetaxel with Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer by Phillips, R., Proudfoot, J., Davicioni, E., Spratt, D.E., Feng, F.Y., Simko, J., Den, R.B., Pollack, A., Rosenthal, S.A., Sartor, O., Sweeney, C., Attard, G., Patel, S.I., Hall, W.A., Efstathiou, J.A., Shah, A.B., Hoffman, K.E., Pugh, S., Sandler, H.M., Tran, P.T.

“…Decipher is a prognostic genomic classifier (GC) validated in several prospective NRG Oncology Phase III trials. Herein, we validate the GC in pre-treatment…”
Get full text

RTOG/NRG 1115 Quality of Life of Phase III Dose Escalated Radiation Therapy (RT) and Standard Androgen Deprivation Therapy (ADT) with GnRH Agonist vs. Dose Escalated RT and ADT with GnRH Agonist and Orteronel (TAK-700) for Men with High-Risk Prostate by Bruner, D.W., Pugh, S., Michaelson, D., Hamstra, D.A., Bachand, F., Master, V., Torres, M., Kaplan, I.D., Rosenthal, S.A., Roach, M., Raben, A., Michalski, J.M., Kavadi, V.S., Ferguson, M., Morgan, S.C., D'Souza, D.P., DeMora, L., Sandler, H.M., Movsas, B.

Get full text

Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) vs. Dose Escalated Radiation Therapy and Enhanced ADT with TAK-700 for Men with High-Risk Prostate Cancer (NRG Oncology/RTOG 1115) by Michaelson, D., Dignam, J.J., Hamstra, D.A., Bachand, F., Master, V., Bruner, D.W., Torres, M., Saylor, P.J., Wallace, R.E., Vapiwala, N., Efstathiou, J.A., Roach, M., Rosenthal, S.A., Raben, A., Morgan, S.C., Kavadi, V.S., Spratt, D.E., Michalski, J.M., Rodgers, J., Sandler, H.M.

Get full text

Association of Black Race With Improved Outcomes Following Definitive Radiotherapy With Androgen Deprivation Therapy for High-Risk Prostate Cancer: A Meta-Analysis of Eight Randomized Trials by Kishan, A.U., Romero, T., Rettig, M., Garraway, I., Roach, M., Pisansky, T.M., Michalski, J.M., Lee, W.R., Jones, C.U., Rosenthal, S.A., Feng, F.Y., Mahal, B.A., Dess, R.T., Nickols, N.G., Tran, P.T., Boutros, P., Steinberg, M.L., Elashoff, D.A., Sandler, H.M., Spratt, D.E.

Get full text